Search PubMed⌕ Search

Biomedical subjects

E Tomas

Publications and source records attributed to E Tomas.

41 records · Page 3Linked to original sources

The effect of ceruloplasmin on the multiplication and on some biological and physico-chemical characteristics of influenza virus A/PR8/34 (H0N1) cultivated in chorioallantoic membrane fragments. Note 2. Modifications occurring in the course of serial passages.

The results obtained at the first passage of ceruloplasmin-incubated influenza virus A/PR8/34 (H0N1) in chorioallantoic membrane fragments demonstrate the "trap effect" of ceruloplasmin and are characterized by the low values of the ratios between the hemagglutinating and neuraminidase activities and the infectivity of the resulted progens. At the 2nd passage, both in the absence and in the presence of ceruloplasmin the previously observed changes are accompanied by severe modifications in the antigenicity of the progens, as shown by the HAI titres obtained against a rabbit antiserum to influenza virus A/PR8/34 (H0N1).

Allantois↗

A probable model of the inhibitory action of ceruloplasmin on the multiplication of some myxo- and paramyxoviruses.

A model of the interaction between virus glycoprotein and the glycoprotein moeity of ceruloplasmia was developed on the ground of previous experimental data referring to the inhibitory action of this enzyme on the multiplication of some influenza and parainfluenza viruses and on their hemagglutinin and neuraminidase activities. The model makes evident the "trap" action exerted by ceruloplasmin on virus particles, both in the early and in the later phases of virus multiplication.

Ceruloplasmin↗

The effect of ceruloplasmin on experimental infection with influenza virus APR 8/34 (H0N1) in the mouse.

Ceruloplasmin administered in different variants confers on mice protection against experimental infection with influenza virus APR 8/34 (H0N1). The optimal variants are: inoculation of an extemporaneous virus-ceruloplasmin mixture, followed by two additional ceruloplasmin applications (which confers maximum protection against initial infection) and the administration of ceruloplasmin prior to virus inoculation (which assures the highest resistance to challenge infection).

Animals↗